Back to Journals » Cancer Management and Research » Volume 16

Feasibility and Tolerability of Anlotinib Plus PD-1 Blockades for Patients with Treatment-Refractory Metastatic Colorectal Cancer: A Retrospective Exploratory Study

Total article views   HTML views PDF downloads Totals
1,673 Dovepress* 1,637+ 22 1,659
PubMed Central* 36 27 63
Totals 1,673 49 1,722
*Since 1 February 2024

View citations on PubMed Central and Google Scholar